Hikma Pharmaceutical reported 1.08B in Operating Expenses for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Artemis Alpha ATS:LN 872K 40K
AstraZeneca AZN:LN 10.51B 1.79B
Bayer BAYN:GR 10.43B 1.33B
Fresenius FRE:GR 8.82B 25M
Fresenius Medical Care FMS:US 4.2B 2.83M
Galapagos GLPG:NA 165.17M 9.07M
Genmab GEN:DC 1.61B 205M
GlaxoSmithKline GSK:LN 6.98B 1.65B
H. Lundbeck A/S LUN:DC 3.5B 550M
Hikma Pharmaceutical HIK:LN 1.08B 209M
Lonza Group LONN:SW 2.33B 108M
Merck MRK:GR 4.03B 149M
Orion ORNBV:FH 199.1M 37.5M
Recordati REC:IM 288.11M 18.51M